Table 1.
Baseline demographics and characteristics of study participants.
| Patient characteristics | Overall (n = 156) |
|---|---|
| Baseline demographics | |
| Age (years), mean ± SD | 55 ± 15 |
| Gender | |
| Male, n (%) | 92 (59) |
| Female, n (%) | 64 (41) |
| Weight (kg), mean ± SD | 74 ± 16.6 |
| Height (m), mean ± SD | 1.66 ± 8.5 |
| BMI (kg/m2), mean ± SD | 26 ± 6 |
| Smoker, n (%) | 29(19) |
| Cause of ESRD | |
| Diabetes mellitus, n (%) | 68 (44) |
| Hypertension, n (%) | 23 (15) |
| Adult polycystic kidney disease, n (%) | 8 (5) |
| Glomerulonephritis, n (%) | 21 (13) |
| Other, n (%) | 19 (12) |
| Unknown, n (%) | 17 (11) |
| Associated comorbidities | |
| Diabetes mellitus, n (%) | 87 (56) |
| Hypertension, n (%) | 108 (69) |
| Dyslipidemia, n (%) | 60 (38) |
| Coronary artery disease, n (%) | 67 (43) |
| Cerebrovascular disease, n (%) | 11 (7) |
| Peripheral vascular disease, n (%) | 34 (22) |
| Time in months since HD initiation, median (range) | 24 (1–216) |
BMI: body mass index; ESRD: end stage renal disease; HD: hemodialysis; CVC: central venous catheter; AVF: arteriovenous fistula; AVG: arteriovenous graft.